naa a22 4500 510763731 CHVBK 20180411083149.0 cr unu---uuuuu 180411e20130301xx s 000 0 eng 10.1007/s12094-012-0906-z doi (NATIONALLICENCE)springer-10.1007/s12094-012-0906-z A high body mass index is not a worse prognostic factor for endometrial carcinoma in a predominantly obese population [Elektronische Daten] [Leonardo Lino-Silva, David de León, Rosa Salcedo-Hernández, Claudia Cavazos-Saman, María Pérez-Montiel] Aim: We investigate if body mass index (BMI, kg×m2) is related to clinical-pathological characteristics in primary tumor and disease outcome in endometrial cancer. Background: Endometrial cancer incidence is increasing in industrialized countries. High BMI is associated with worse prognosis for many diseases. Introduction: Endometrial carcinoma is the most common gynecological malignancy in industrialized countries and the incidence has been increasing over the last few decades associated with obesity, however, it is not clear if a high BMI is associated with poor prognosis. Patients and methods: In total, 147 women primarily treated for endometrial carcinoma at the Instituto Nacional de Cancerología during 2000-2005 were studied. Body mass index was available for all patients and related to comprehensive clinical and histopathological data. Results: High BMI was related to endometrioid histology and low/intermediate grade, and overweight/obese women had the same survival as the normal/underweight women. In survival analysis adjusting for age, histological subtype and grade, BMI showed no independent prognostic impact. Conclusion: High BMI was significantly associated with markers of non-aggressive disease and women with high BMI had the same survival time in univariate analysis. Federación de Sociedades Españolas de Oncología (FESEO), 2012 Endometrial carcinoma nationallicence Endometrioid adenocarcinoma nationallicence Body mass index nationallicence Obesity nationallicence Female cancer nationallicence Lino-Silva Leonardo Anatomic Pathology, Instituto Nacional de Cancerología de México, Av. San Fernando 22 Col. Sección XVI, Mexico City, Mexico aut de León David Ginecologycal Oncology, Instituto Nacional de Cancerología de México, Mexico City, Mexico aut Salcedo-Hernández Rosa Ginecologycal Oncology, Instituto Nacional de Cancerología de México, Mexico City, Mexico aut Cavazos-Saman Claudia Anatomic Pathology, Instituto Nacional de Cancerología de México, Av. San Fernando 22 Col. Sección XVI, Mexico City, Mexico aut Pérez-Montiel María Anatomic Pathology, Instituto Nacional de Cancerología de México, Av. San Fernando 22 Col. Sección XVI, Mexico City, Mexico aut Clinical and Translational Oncology Springer Milan 15/3(2013-03-01), 243-247 1699-048X 15:3<243 2013 15 12094 https://doi.org/10.1007/s12094-012-0906-z text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s12094-012-0906-z text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Lino-Silva Leonardo Anatomic Pathology, Instituto Nacional de Cancerología de México, Av. San Fernando 22 Col. Sección XVI, Mexico City, Mexico aut NATIONALLICENCE 700 1- de León David Ginecologycal Oncology, Instituto Nacional de Cancerología de México, Mexico City, Mexico aut NATIONALLICENCE 700 1- Salcedo-Hernández Rosa Ginecologycal Oncology, Instituto Nacional de Cancerología de México, Mexico City, Mexico aut NATIONALLICENCE 700 1- Cavazos-Saman Claudia Anatomic Pathology, Instituto Nacional de Cancerología de México, Av. San Fernando 22 Col. Sección XVI, Mexico City, Mexico aut NATIONALLICENCE 700 1- Pérez-Montiel María Anatomic Pathology, Instituto Nacional de Cancerología de México, Av. San Fernando 22 Col. Sección XVI, Mexico City, Mexico aut NATIONALLICENCE 773 0- Clinical and Translational Oncology Springer Milan 15/3(2013-03-01), 243-247 1699-048X 15:3<243 2013 15 12094 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer